DE60130628D1 - Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- DE60130628D1 DE60130628D1 DE60130628T DE60130628T DE60130628D1 DE 60130628 D1 DE60130628 D1 DE 60130628D1 DE 60130628 T DE60130628 T DE 60130628T DE 60130628 T DE60130628 T DE 60130628T DE 60130628 D1 DE60130628 D1 DE 60130628D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- group
- pharmaceutical compositions
- compositions containing
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000112100 | 2000-04-13 | ||
JP2000112100 | 2000-04-13 | ||
PCT/JP2001/003198 WO2001079170A2 (en) | 2000-04-13 | 2001-04-13 | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60130628D1 true DE60130628D1 (de) | 2007-11-08 |
DE60130628T2 DE60130628T2 (de) | 2008-07-10 |
Family
ID=18624324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60130628T Expired - Fee Related DE60130628T2 (de) | 2000-04-13 | 2001-04-13 | Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (12)
Country | Link |
---|---|
US (2) | US7067533B2 (de) |
EP (1) | EP1228367B1 (de) |
JP (1) | JP2004501079A (de) |
KR (1) | KR100853968B1 (de) |
CN (1) | CN1264821C (de) |
AT (1) | ATE374366T1 (de) |
AU (1) | AU784930B2 (de) |
CA (1) | CA2370487A1 (de) |
DE (1) | DE60130628T2 (de) |
ES (1) | ES2291308T3 (de) |
HU (1) | HUP0203383A3 (de) |
WO (1) | WO2001079170A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1434765B1 (de) * | 2001-09-14 | 2009-12-02 | High Point Pharmaceuticals, LLC | Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren |
US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
EP1968961A2 (de) | 2005-12-21 | 2008-09-17 | Decode Genetics EHF | Heterocyclische, stickstoffhaltige biarylinhibitoren von lta4h zur behandlung von entzündungen |
DE102005062990A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln |
US8592435B2 (en) * | 2007-04-27 | 2013-11-26 | Daiichi Sankyo Company, Limited | Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
US20180305334A1 (en) * | 2015-10-14 | 2018-10-25 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
KR20190015748A (ko) | 2016-06-08 | 2019-02-14 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Atf4 경로 억제제로서의 화학적 화합물 |
CN111285820A (zh) * | 2018-12-07 | 2020-06-16 | 成都康弘药业集团股份有限公司 | 一种枸橼酸莫沙必利有关物质及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW204411B (de) * | 1991-06-05 | 1993-04-21 | Tokyo Electron Co Ltd | |
EP0982026B1 (de) * | 1998-08-18 | 2006-05-17 | F. Hoffmann-La Roche Ag | Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-Rezeptorblockern |
WO2000023076A1 (en) * | 1998-10-16 | 2000-04-27 | Suntory Limited | Aminophenoxyacetic acid derivatives as neuroprotectants |
-
2001
- 2001-04-13 ES ES01921835T patent/ES2291308T3/es not_active Expired - Lifetime
- 2001-04-13 US US10/009,566 patent/US7067533B2/en not_active Expired - Fee Related
- 2001-04-13 CN CNB018009085A patent/CN1264821C/zh not_active Expired - Fee Related
- 2001-04-13 AU AU48762/01A patent/AU784930B2/en not_active Ceased
- 2001-04-13 KR KR1020017015979A patent/KR100853968B1/ko not_active IP Right Cessation
- 2001-04-13 DE DE60130628T patent/DE60130628T2/de not_active Expired - Fee Related
- 2001-04-13 CA CA002370487A patent/CA2370487A1/en not_active Abandoned
- 2001-04-13 AT AT01921835T patent/ATE374366T1/de not_active IP Right Cessation
- 2001-04-13 EP EP01921835A patent/EP1228367B1/de not_active Expired - Lifetime
- 2001-04-13 HU HU0203383A patent/HUP0203383A3/hu unknown
- 2001-04-13 WO PCT/JP2001/003198 patent/WO2001079170A2/en active IP Right Grant
- 2001-04-13 JP JP2001576772A patent/JP2004501079A/ja not_active Abandoned
-
2006
- 2006-01-24 US US11/337,664 patent/US20060178401A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2291308T3 (es) | 2008-03-01 |
JP2004501079A (ja) | 2004-01-15 |
ATE374366T1 (de) | 2007-10-15 |
KR100853968B1 (ko) | 2008-08-25 |
HUP0203383A2 (hu) | 2003-02-28 |
EP1228367B1 (de) | 2007-09-26 |
KR20020016830A (ko) | 2002-03-06 |
EP1228367A2 (de) | 2002-08-07 |
AU4876201A (en) | 2001-10-30 |
CN1449493A (zh) | 2003-10-15 |
CA2370487A1 (en) | 2001-10-25 |
US20030139447A1 (en) | 2003-07-24 |
WO2001079170A2 (en) | 2001-10-25 |
WO2001079170A3 (en) | 2002-06-13 |
US7067533B2 (en) | 2006-06-27 |
CN1264821C (zh) | 2006-07-19 |
DE60130628T2 (de) | 2008-07-10 |
AU784930B2 (en) | 2006-08-03 |
US20060178401A1 (en) | 2006-08-10 |
HUP0203383A3 (en) | 2003-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0401889A2 (hu) | 1,8-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények | |
DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
HUP0202757A2 (hu) | Metabotróp glutamát receptor antagonista heteropoliciklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és a vegyületek alkalmazása | |
NZ337118A (en) | 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same useful in treating or preventing arteriosclerotic and/or hyper-lipemia disease, pancreatitis, obesity, hypercholesterolemia and hypertriglyceridemia. | |
HUP9603298A2 (hu) | Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása, a vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
EA200500174A1 (ru) | Новые производные бензимидазола, полезные в качестве антипролиферативных агентов | |
SE0104332D0 (sv) | Therapeutic agents | |
IS2293B (is) | Arýl sambrædd asapólýsýklísk efnasambönd | |
EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
HUP0001062A2 (hu) | NAALADáz gátló hatású foszfinsavszármazékokat tartalmazó gyógyászati készítmények | |
ES2150353A1 (es) | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. | |
AP1816A (en) | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists. | |
RO112111B1 (ro) | Compuşi heterobiciclici, procedee pentru prepararea acestora şi compoziţii farmaceutice care îi conţin | |
PT842923E (pt) | Derivados do pirrolo e composicoes medicinais | |
EA200300071A1 (ru) | Терапевтический препарат для лечения невроза страха (тревоги) или депрессии и производные пиперазина | |
ATE233754T1 (de) | Diphenyl-piperidin derivate | |
DE60130628D1 (de) | Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen | |
DE60112725D1 (de) | Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors | |
DE69925160D1 (de) | Arylpiperidin- und aryl-1,2,5,6-tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität | |
DE60110233D1 (de) | Neue n-(2-phenyl-3-aminopropyl)naphtamide | |
ATE315023T1 (de) | Aminoalkylpyrrolidine als serotoninrezeptorliganden sowie diese enthaltende zusammensetzungen, pharmazeutische verwendungen und methoden zu deren synthese | |
DE60143671D1 (de) | Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists | |
RU2004114262A (ru) | Нейротензии активные производные 2,3-диарилпиразолидина | |
ATE245155T1 (de) | N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |